Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms

References

• SpellbergBGuidosRGilbertDThe epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaClin Infect Dis200846215516418171244
   PubMed Web of Science ®Google Scholar
• BoucherHWTalbotGHBradleyJSBad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of AmericaClin Infect Dis200948111219035777
   PubMed Web of Science ®Google Scholar
• LaxminarayanRRexJHAntibacterial R&D incentivesNat Rev Drug Discov2011101072772821959280
   PubMed Web of Science ®Google Scholar
• ShlaesDavid MAntibiotics: The Perfect Storm Available from: https://bfosinfo.files.wordpress.com/2010/09/9048190568antibiotics.pdfAccessed August 24, 2016
   Google Scholar
• SpellbergBSharmaPRexJHThe critical impact of time discounting on economic incentives to overcome the antibiotic market failureNat Rev Drug Discov201211216822293569
   PubMed Web of Science ®Google Scholar
• DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
   PubMed Web of Science ®Google Scholar
• EveraertKLumenNKerckhaertWWillaertPvan DrielMUrinary tract infections in spinal cord injury: prevention and treatment guidelinesActa Clin Belg200964433534019810421
   PubMed Web of Science ®Google Scholar
• HannamanMJErtlMJPatients with immunodeficiencyMed Clin North Am20139761139115924182724
   PubMed Web of Science ®Google Scholar
• PetersEJLipskyBADiagnosis and management of infection in the diabetic footMed Clin North Am201397591194623992901
   PubMed Web of Science ®Google Scholar
• CarmeliYAkovaMCornagliaGControlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection controlClin Microbiol Infect201016210211120085604
   PubMed Web of Science ®Google Scholar
• El SalabiAWalshTRChouchaniCExtended spectrum beta-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteriaCrit Rev Microbiol201339211312222667455
   PubMed Web of Science ®Google Scholar
• SavardPPerlTMA call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settingsCurr Opin Infect Dis20122537137722766646
   PubMedGoogle Scholar
• JohnsonJWFisherJFMobasherySBacterial cell-wall recyclingAnn N Y Acad Sci20131277547523163477
   PubMed Web of Science ®Google Scholar
• LeeHVazquez-LaslopNKlyachkoKANeyfakhAAIsolation of antibiotic hypersusceptibility mutants of Acinetobacter spp. by selection for DNA releaseAntimicrob Agents Chemother20034741267127412654657
   PubMed Web of Science ®Google Scholar
• PotvinELehouxDEKukavica-IbruljIIn vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targetsEnviron Microbiol20035121294130814641575
   PubMed Web of Science ®Google Scholar
• BonisMWilliamsAGuadagniniSWertsCBonecaIGThe effect of bulgecin A on peptidoglycan metabolism and physiology of Helicobacter pyloriMicrob Drug Resist201218323023922432710
   PubMed Web of Science ®Google Scholar
• TemplinMFEdwardsDHHoltjeJVA murein hydrolase is the specific target of bulgecin in Escherichia coliJ Biol Chem19922672820039200431400320
   PubMed Web of Science ®Google Scholar
• van AsseltEJThunnissenAMDijkstraBWHigh resolution crystal structures of the Escherichia coli lytic transglycosylase Slt70 and its complex with a peptidoglycan fragmentJ Mol Biol1999291487789810452894
   PubMed Web of Science ®Google Scholar
• ClemmerKMBonomoRARatherPNGenetic analysis of surface motility in Acinetobacter baumanniiMicrobiology2011157Pt 92534254421700662
   PubMedGoogle Scholar
• CarruthersMDHardingCMBakerBDDraft genome sequence of the clinical isolate Acinetobacter nosocomialis strain M2Genome Announc201316e00906e0091324201195
   PubMedGoogle Scholar
• ThunnissenAMRozeboomHJKalkKHDijkstraBWStructure of the 70-kDa soluble lytic transglycosylase complexed with bulgecin A. implications for the enzymatic mechanismBiochemistry1995343912729127377548026
   PubMed Web of Science ®Google Scholar
• ImadaAKintakaKNakaoMShinagawaSBulgecin, a bacterial metabolite which in concert with beta-lactam antibiotics causes bulge formationJ Antibiot (Tokyo)19823510140014036757229
   PubMed Web of Science ®Google Scholar
• GwynnMNBoxSJBrownAGGilpinMLMM 42842, a new member of the monobactam family produced by Pseudomonas cocovenenans. I. Identification of the producing organismJ Antibiot (Tokyo)1988411163346181
   PubMed Web of Science ®Google Scholar
• ShinagawaSMakiMKintakaKImadaAAsaiMIsolation and characterization of bulgecins, new bacterial metabolites with bulge-inducing activityJ Antibiot (Tokyo)198538117233918981
   PubMed Web of Science ®Google Scholar
• NakaoMYukishigeKKondoMImadaANovel morphological changes in gram-negative bacteria caused by combination of bulgecin and cefmenoximeAntimicrob Agents Chemother19863034144173535665
   PubMed Web of Science ®Google Scholar
• PerezFEndimianiARayAJCarbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on disseminationJ Antimicrob Chemother20106581807181820513702
   PubMed Web of Science ®Google Scholar
• SimmAMLoveridgeEJCrosbyJAvisonMBWalshTRBennettPMBulgecin A: a novel inhibitor of binuclear metallo-beta-lactamasesBiochem J2005387Pt 358559015569001
   PubMedGoogle Scholar
• NordmannPPoirelLWalshTRLivermoreDMThe emerging NDM carbapenemasesTrends Microbiol2011191258859522078325
   PubMed Web of Science ®Google Scholar
• PerezFRayAJDumfordDJacobsMBonomoRAC2-720 Metallo-b-lactamases in the Heartland of the United States: International Strain of VIM-2 producing Pseudomonas aeruginosa in a Community Hospital in Northeast Ohio52nd Interscience Conference on antimicrobial agents and chemotherapeutics2012San Francisco; CA
   Google Scholar
• PerezFHujerAMMarshallSHExtensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast OhioAntimicrob Agents Chemother201458105929593525070102
   PubMed Web of Science ®Google Scholar
• WinklerMLPapp-WallaceKMHujerAMUnexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosaAntimicrob Agents Chemother20155921020102925451057
   PubMed Web of Science ®Google Scholar
• WrightMSHaftDHHarkinsDMNew insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysismBio201451e00963e0091324449752
   PubMed Web of Science ®Google Scholar
• HeidrichCTemplinMFUrsinusAInvolvement of N-acetylmuramyl-L-alanine amidases in cell separation and antibiotic-induced autolysis of Escherichia coliMol Microbiol200141116717811454209
   PubMed Web of Science ®Google Scholar
• CLSIMethods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard9th edCLSI document M07-A9Wayne, PAClinical and Laboratory Standards Institute2012
   Google Scholar
• MesarosNGlupczynskiYAvrainLCaceresNETulkensPMVan BambekeFA combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosaJ Antimicrob Chemother200759337838617289770
   PubMed Web of Science ®Google Scholar
• ClarkeCAScheurwaterEMClarkeAJThe vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylaseJ Biol Chem201028520148431484720351104
   PubMed Web of Science ®Google Scholar
• HujerKMHujerAMHultenEAAnalysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical CenterAntimicrob Agents Chemother200650124114412317000742
   PubMed Web of Science ®Google Scholar
• Garcia-SaezIDocquierJDRossoliniGMDidebergOThe three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised formJ Mol Biol2008375360461118061205
   PubMed Web of Science ®Google Scholar
• DocquierJDLamotte-BrasseurJGalleniMAmicosanteGFrèreJMRossoliniGMOn functional and structural heterogeneity of VIM-type metallo-b-lactamasesJ Antimicrob Chemother200351225726612562689
   PubMed Web of Science ®Google Scholar